Rami A. Alzahrani

Rami A. Alzahrani

Auto-generated profile, based on publicly available information

Rami A. Alzahrani

King Abdulaziz University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2023 in Journal of Tissue Viability
Verified
Journal Article
Closed access
MAMaram Taha Alkhatieb
Maram Taha Alkhatieb
HAHussain A. Alkhalifah
Hussain A. Alkhalifah
ZAZainab A. Alkhalifah
Zainab A. Alkhalifah
KAKhalid M. Aljehani
Khalid M. Aljehani
MAMohammed S. Almalki
Mohammed S. Almalki
RARami A. Alzahrani
Rami A. Alzahrani

7 May 2026 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
SASalman M. Alosaimi
Salman M. Alosaimi
NANasser Eid Alotaibi
Nasser Eid Alotaibi
AMAbdullah Malek
Abdullah Malek
BABander Aljarallah
Bander Aljarallah
SASaja A. Alharbi
Saja A. Alharbi
SASharif Almatrafi
Sharif Almatrafi
Objectives: Idiopathic sudden sensorineural hearing loss (ISSNHL) is a rapidly progressive disease that may cause permanent hearing loss. Standard primary treatments include oral corticosteroids (OCs) or intratympanic corticosteroids (ITCs). This study aimed to evaluate the effectiveness and safety of OCs versus ITCs as primary treatments for ISSNHL. Design: This systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched Medline, Google Scholar, Web of Science, Embase, and Scopus, identifying 11 RCTs comprising 833 patients. Results: Both OCs and ITCs significantly improved hearing, with average pure tone audiometry (PTA) gains ranging from 12 to 40 dB. No significant between-intervention difference was observed in post-treatment PTA. Generally, combination therapy yielded the greatest improvements (>40 dB and >60% recovery). OCs caused systemic adverse effects, whereas ITCs produced mostly mild local effects. Conclusions: Both treatment routes effectively improved hearing in patients with ISSNHL, with neither demonstrating clear superiority in overall efficacy. However, combination therapy may be associated with better hearing outcomes.